Literature DB >> 28616649

Earlier Pulmonary Valve Replacement in Down Syndrome Patients Following Tetralogy of Fallot Repair.

Rachel T Sullivan1, Peter C Frommelt2, Garick D Hill3.   

Abstract

The association between Down syndrome and pulmonary hypertension could contribute to more severe pulmonary regurgitation after tetralogy of Fallot repair and possibly earlier pulmonary valve replacement. We compared cardiac magnetic resonance measures of pulmonary regurgitation and right ventricular dilation as well as timing of pulmonary valve replacement between those with and without Down syndrome after tetralogy of Fallot repair. Review of our surgical database from 2000 to 2015 identified patients with tetralogy of Fallot with pulmonary stenosis. Those with Down syndrome were compared to those without. The primary outcome of interest was time from repair to pulmonary valve replacement. Secondary outcomes included pulmonary regurgitation and indexed right ventricular volume on cardiac magnetic resonance imaging. The cohort of 284 patients included 35 (12%) with Down syndrome. Transannular patch repair was performed in 210 (74%). Down syndrome showed greater degree of pulmonary regurgitation (55 ± 14 vs. 37 ± 16%, p = 0.01) without a significantly greater rate of right ventricular dilation (p = 0.09). In multivariable analysis, Down syndrome (HR 2.3, 95% CI 1.2-4.5, p = 0.02) and transannular patch repair (HR 5.5, 95% CI 1.7-17.6, p = 0.004) were significant risk factors for valve replacement. Those with Down syndrome had significantly lower freedom from valve replacement (p = 0.03). Down syndrome is associated with an increased degree of pulmonary regurgitation and earlier pulmonary valve replacement after tetralogy of Fallot repair. These patients require earlier assessment by cardiac magnetic resonance imaging to determine timing of pulmonary valve replacement and evaluation for and treatment of preventable causes of pulmonary hypertension.

Entities:  

Keywords:  Down syndrome; Magnetic resonance imaging; Pulmonary valve; Tetralogy of Fallot

Mesh:

Year:  2017        PMID: 28616649     DOI: 10.1007/s00246-017-1653-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

Review 1.  Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair.

Authors:  Tal Geva
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2006

2.  Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair.

Authors:  Judith Therrien; Yves Provost; Naeem Merchant; William Williams; Jack Colman; Gary Webb
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

3.  Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot.

Authors:  James S Tweddell; Pippa Simpson; Shun-Hwa Li; Jennifer Dunham-Ingle; Peter J Bartz; Michael G Earing; Andrew N Pelech
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2012

4.  Patients with Down syndrome and congenital heart disease: survival is improving, but challenges remain.

Authors:  Konstantinos Dimopoulos; Aleksander Kempny
Journal:  Heart       Date:  2016-06-27       Impact factor: 5.994

5.  Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin.

Authors:  Hiroyuki Fukushima; Kenjiro Kosaki; Reiko Sato; Tatsuhiko Yagihashi; Ryohei Gatayama; Kazuki Kodo; Takuya Hayashi; Maki Nakazawa; Takatoshi Tsuchihashi; Jun Maeda; Yoshifumi Kojima; Hiroyuki Yamagishi; Takao Takahashi
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

6.  Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of fallot.

Authors:  Eddie Wai-Yin Cheung; Wilfred Hang-Sang Wong; Yiu-Fai Cheung
Journal:  Am J Cardiol       Date:  2010-08-15       Impact factor: 2.778

7.  Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot.

Authors:  J G Murphy; B J Gersh; D D Mair; V Fuster; M D McGoon; D M Ilstrup; D C McGoon; J W Kirklin; G K Danielson
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

8.  Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades.

Authors:  Edward J Hickey; Gruschen Veldtman; Timothy J Bradley; Aungkana Gengsakul; Cedric Manlhiot; William G Williams; Gary D Webb; Brian W McCrindle
Journal:  Eur J Cardiothorac Surg       Date:  2008-10-09       Impact factor: 4.191

9.  Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005.

Authors:  Mark D Reller; Matthew J Strickland; Tiffany Riehle-Colarusso; William T Mahle; Adolfo Correa
Journal:  J Pediatr       Date:  2008-07-26       Impact factor: 4.406

10.  Pulmonary hypoplasia in Down's syndrome.

Authors:  T P Cooney; W M Thurlbeck
Journal:  N Engl J Med       Date:  1982-11-04       Impact factor: 91.245

View more
  1 in total

1.  Syndromic and Non-Syndromic Patients with Repaired Tetralogy of Fallot: Does It Affect the Long-Term Outcome?

Authors:  Giulio Calcagni; Camilla Calvieri; Anwar Baban; Francesco Bianco; Rosaria Barracano; Massimo Caputo; Andrea Madrigali; Stefani Silva Kikina; Marco Alfonso Perrone; Maria Cristina Digilio; Marco Pozzi; Aurelio Secinaro; Berardo Sarubbi; Lorenzo Galletti; Maria Giulia Gagliardi; Andrea de Zorzi; Fabrizio Drago; Benedetta Leonardi
Journal:  J Clin Med       Date:  2022-02-06       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.